Stockman Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
724
-15
-2% -$5.13K 0.03% 156
2026
Q1
$260K Buy
+739
New +$263K 0.03% 152
2025
Q4
Sell
-716
Closed -$202K 180
2025
Q3
$202K Buy
+716
New +$208K 0.03% 172
2025
Q2
Sell
-689
Closed -$215K 174
2025
Q1
$215K Buy
+689
New +$203K 0.03% 154
2024
Q4
Sell
-707
Closed -$228K 167
2024
Q3
$228K Sell
707
-4
-0.6% -$1.31K 0.04% 164
2024
Q2
$222K Buy
+711
New +$209K 0.04% 159

Other funds holding AMGN

Stockman Wealth Management's AMGN Position: Q2 2026 in Review

Stockman Wealth Management reduced its Amgen (AMGN) stake by 2% in Q2 2026, selling an estimated $5.13K and leaving 724 shares worth $262K. The position accounts for 0.03% of the portfolio, ranked #156.

Stockman Wealth Management first reported a position in AMGN in Q2 2024 and has held it in 6 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Stockman Wealth Management held 724 shares of Amgen worth $262K as of Q2 2026.
  • Stockman Wealth Management sold 15 Amgen shares in Q2 2026, an estimated $5.13K.
  • Amgen made up 0.03% of Stockman Wealth Management's portfolio in Q2 2026, its #156 holding.
  • Stockman Wealth Management first reported a position in Amgen in Q2 2024 and has held it in 6 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Stockman Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.